Press Coverage, Opinion Arda Ozcubukcu 22/06/2023 Press Coverage, Opinion Arda Ozcubukcu 22/06/2023 Will the UK’s ambitious life sciences investment power-up the psychedelic sector? Read More Announcement Clerkenwell Press Office 26/05/2022 Announcement Clerkenwell Press Office 26/05/2022 Clerkenwell Health Taps Top Academics and Expands Pan-European Scientific Advisory Board Read More Announcement Clerkenwell Press Office 12/05/2022 Announcement Clerkenwell Press Office 12/05/2022 Why we’re opening Europe’s first commercial psychedelic research facility Read More Announcement Clerkenwell Press Office 10/05/2022 Announcement Clerkenwell Press Office 10/05/2022 Clerkenwell Health launches new therapist free training programme to remove bottlenecks in the psychedelic industry Read More Announcement Clerkenwell Press Office 08/09/2021 Announcement Clerkenwell Press Office 08/09/2021 Danish and British Psychedelic Startups Partner to Bring Innovative Psychedelics to Patients Read More Announcement Clerkenwell Press Office 10/08/2021 Announcement Clerkenwell Press Office 10/08/2021 Clerkenwell Partners with Leading Preclinical CRO Transpharmation to Advance Psychedelic Clinical Trials in Europe Read More Announcement Clerkenwell Press Office 16/07/2021 Announcement Clerkenwell Press Office 16/07/2021 Leading British Academic Joins Clerkenwell’s Advisory Board Read More Announcement Clerkenwell Press Office 07/07/2021 Announcement Clerkenwell Press Office 07/07/2021 Clerkenwell Signs First Multi-Million Pound Contract with International Psychedelic Bio-Tech Company Read More Announcement Clerkenwell Press Office 25/06/2021 Announcement Clerkenwell Press Office 25/06/2021 UK Set To Become Hub Of Psychedelic Research Read More
Press Coverage, Opinion Arda Ozcubukcu 22/06/2023 Press Coverage, Opinion Arda Ozcubukcu 22/06/2023 Will the UK’s ambitious life sciences investment power-up the psychedelic sector? Read More
Announcement Clerkenwell Press Office 26/05/2022 Announcement Clerkenwell Press Office 26/05/2022 Clerkenwell Health Taps Top Academics and Expands Pan-European Scientific Advisory Board Read More
Announcement Clerkenwell Press Office 12/05/2022 Announcement Clerkenwell Press Office 12/05/2022 Why we’re opening Europe’s first commercial psychedelic research facility Read More
Announcement Clerkenwell Press Office 10/05/2022 Announcement Clerkenwell Press Office 10/05/2022 Clerkenwell Health launches new therapist free training programme to remove bottlenecks in the psychedelic industry Read More
Announcement Clerkenwell Press Office 08/09/2021 Announcement Clerkenwell Press Office 08/09/2021 Danish and British Psychedelic Startups Partner to Bring Innovative Psychedelics to Patients Read More
Announcement Clerkenwell Press Office 10/08/2021 Announcement Clerkenwell Press Office 10/08/2021 Clerkenwell Partners with Leading Preclinical CRO Transpharmation to Advance Psychedelic Clinical Trials in Europe Read More
Announcement Clerkenwell Press Office 16/07/2021 Announcement Clerkenwell Press Office 16/07/2021 Leading British Academic Joins Clerkenwell’s Advisory Board Read More
Announcement Clerkenwell Press Office 07/07/2021 Announcement Clerkenwell Press Office 07/07/2021 Clerkenwell Signs First Multi-Million Pound Contract with International Psychedelic Bio-Tech Company Read More
Announcement Clerkenwell Press Office 25/06/2021 Announcement Clerkenwell Press Office 25/06/2021 UK Set To Become Hub Of Psychedelic Research Read More